Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Martin H. Huber, M.D.$454.9M
Market Cap • 16/04/20242001
(há 23 anos)
2017
(7 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts228
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MRSNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.